Advertisement Press Releases Archive - Page 132 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Peristaltic Pump Specialist Launches Fully Integrated Drive for OEM Pumps

    Watson-Marlow Pumps Group introduces DriveSure™ its new panel-mount OEM brushless DC gear motor with fully integrated speed controller. DriveSure is highly adaptable, offering 24V and 48V dc options, a 51:1 control ratio between 408-8 rpm, and directly accepts market-standard analogue control signals. With DriveSure, OEM engineers can bring products to market faster and with less engineering cost by eliminating the time, design uncertainty and risks associated with the separate specification of pump motor, gearbox and drive.

  • COPA-DATA begins research project on intelligent user interfaces

    With the rise in the use of modern hardware technology in the industrial environment, such as Smartphones and tablets, there is also an increasing demand for new operating, interaction and visualization concepts. Within the framework of the research project "zenon Smart Interfaces" COPA-DATA is addressing these new market requirements and thereby extending its range of automation solutions for mobile devices.

  • India Regulatory Update

    The Central Drugs Standard Control Organization (CDSCO), the national regulatory body governing pharmaceuticals and medical devices in India, issued draft guidelines earlier this year designed to ensure the quality and identity of pharmaceutical products throughout the distribution process.

  • New EU GDP Guideline

    After almost two years of review, an updated GDP guideline for EU distribution of medicinal products for human use was published in the Official Journal of the European Union on March 7, 2013. This new guideline replaces existing directives (94/C 63/03) that have been in effect since 1994. Compliance with the 2013 EU Guideline (2013/C 68/01) becomes mandatory six months after date of publication, or on September 7, 2013.

  • novel R&D PEF systems for pharmaceutical applications from SteriBeam

    For R&D in non-invasive sterilization of pharmaceutical liquid products, as well as for extraction of pharmaceutical nutrients from vegetative cells, SteriBeam developed novel bench-top semi-automatic and fully automatic PEF (pulsed electrical field) systems. These systems have many advantages as to conventional PEF systems.

  • Analysis of complex protein-protein-interactions made easy: ChromoTek’s fluorescent two hybrid (F2H®) technology enables screening and validation of compounds in living cells

    ChromoTek has developed a series of highly sensitive protein-protein-interaction (PPI) assays to screen compounds that resolve the binding of two proteins within cells. The so-called fluorescent two hybrid (F2H®) technology is based on a proprietary cell line that contains a spot-like landing platform where one interaction partner binds.